Continuity in Care®: Best Practices in Immunoglobulin Therapy—Improving Quality of Life for Patients With Primary Immunodeficiency
January 6, 2022
January 6, 2023
Scroll to the Bottom of this Information to Begin this Course
This activity is provided by Physicians’ Education Resource®, LLC.
This activity is supported by an educational grants from CSL Behring, LLC and Grifols.
- Physicians — maximum of 1.5 AMA PRA Category 1 Credit(s)™
- Nurses — 1.5 Contact Hours
All other healthcare professionals completing this course will be issued a statement of participation.
These activities are intended for an audience of immunologists, infusion nurses, pediatricians, nurse practitioners, physician assistants, and pharmacists involved in the dispensing and administration of immunoglobulin replacement therapy (IgG) for patients with PI.
This video-based program is designed to help health care professionals explore treatment options for patients with primary immunodeficiency (PI) through a unique perspective: putting the patient voice front and center. A patient will lend her expertise to this program by sharing her journey living with PI. This online activity focuses on diagnostic considerations, patient- and disease-related factors that affect the use of intravenous (IVIg) or subcutaneous immunoglobulin (SCIg), and ways to individualize each patient’s treatment using a multidisciplinary team.
Upon completion of this activity, participants should be better able to:
- Discuss the disease burden of PI as related to quality of life (QOL)
- Select an optimal route of administration for immunoglobulin therapy based on clinical presentation and goals of therapy
- Analyze the efficacy and safety data regarding the use of subcutaneous immunoglobulin SCIg products in patients with PI
- Describe best practices for optimal administration of SCIg in the management of PI
- Identify appropriate infusion devices and ancillary supplies that align with patient preferences
Bob Geng, MD
Associate Clinical Voluntary Professor
UC San Diego School of Medicine
President, San Diego Allergy Society
Co-Director, AAFA-Rady Children’s Hospital Severe Asthma Program
Allergy/Immunology Director of the Multidisciplinary Atopic Dermatitis ProgramSan Diego, CA
Elizabeth Duruz, RPh, CSP, IgCP
Regional Clinical Pharmacist
Kristin Epland, MSN, FNP-C
Nurse Advisory Committee
Immune Deficiency Foundation
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible entities.
Bob Geng, MD
- Consultant: Takeda, Grifols, Pfizer, KORU Medical Systems, Kedrion Biopharma, Bio Products Laboratory
- Speaker’s Bureau: Takeda, Grifols
Elizabeth Duruz, RPh, CSP, IgCP, has no relevant financial relationships with ineligible companies.
Kristin Epland, MSN, FNP-C
- Consultant:: Takeda Pharmaceutical Company
- Speaker’s Bureau: Takeda Pharmaceutical Company
Joan Schwarz, has no relevant financial relationships with ineligible companies.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Instructions for Participation and Credit
- Complete the activity (including pre- and post-activity assessments).
- Answer the evaluation questions.
- Request credit using the drop-down menu.
Course Viewing Requirements
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.